Northwest Biothrputcs Inc
(NWBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 179,126 | 45,806 | 287 | -4,123 | -529,821 |
| Depreciation Amortization | 2,625 | 1,961 | 1,651 | 11,105 | 3,100 |
| Accounts payable and accrued liabilities | 77 | 2,351 | N/A | 876 | 2,133 |
| Other Working Capital | 2,725 | 3,420 | -210 | -2,389 | -35 |
| Other Operating Activity | -222,852 | -80,591 | -21,768 | -18,717 | 492,530 |
| Operating Cash Flow | $-38,299 | $-27,053 | $-20,040 | $-13,248 | $-32,093 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,015 | -4,462 | -1,771 | -264 | -6,610 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -1,532 |
| Investing Cash Flow | $-6,015 | $-4,462 | $-1,771 | $-264 | $-8,142 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,665 | 13,574 | 12,288 | 10,000 | 13,987 |
| Debt Repayment | -5,828 | N/A | N/A | N/A | -468 |
| Common Stock Issued | 24,045 | 12,124 | 4,089 | 761 | 40,729 |
| Other Financing Activity | 250 | -1,236 | -835 | 0 | -1,552 |
| Financing Cash Flow | $48,132 | $24,462 | $15,542 | $10,761 | $52,696 |
| Exchange Rate Effect | 1,368 | 906 | 44 | 236 | -2,850 |
| Beginning Cash Position | 9,983 | 9,983 | 9,983 | 9,983 | 372 |
| End Cash Position | 15,169 | 3,836 | 3,758 | 7,468 | 9,983 |
| Net Cash Flow | $5,186 | $-6,147 | $-6,225 | $-2,515 | $9,611 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,299 | -27,053 | -20,040 | -13,248 | -32,093 |
| Capital Expenditure | -6,015 | -4,462 | -1,771 | -264 | -6,610 |
| Free Cash Flow | -44,314 | -31,515 | -21,811 | -13,512 | -38,703 |